Apoptosis as a biomarker in chemoprevention trials

Urology

Volumn 57, Issue 4, 2001, Pages 141-142

  Riss, T L ^a  

^a PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE; DNA FRAGMENT; PROTEINASE;

APOPTOSIS; ASSAY; CANCER PREVENTION; CELL STRUCTURE; CONFERENCE PAPER; DISEASE MARKER; ENZYME ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

ANTIBODIES; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; DNA FRAGMENTATION; EPITOPES; HUMANS; IN SITU NICK-END LABELING; MALE;

EID: 0034965131     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00960-2     Document Type: Conference Paper

References (6)

1. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
2. Cleaved PARP as a marker for apoptosis in tissue sections
3. Caspase structure, proteolytic substrates, and function during apoptosis
4. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis
5. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
6. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis